Avoro Capital Advisors LLC Blueprint Medicines Corp Put Options Transaction History
Avoro Capital Advisors LLC
- $6.18 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
390Shares Held
68.6MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$665 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$664 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$542 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$308 Million0.05% of portfolio
-
State Street Corp Boston, MA2.68MShares$269 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.98B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...